Company news
BioCardia, Inc. news in 2021
BioCardia, Inc.'s news releases, calls and decks from 2021, newest first.
BioCardia Establishes New Manufacturing Facility to Enable Its Cell Therapy Product Candidates
December 14, 2021
BioCardia Reports Third Quarter 2021 Financial Results and Business Highlights
November 9, 2021
BioCardia To Release Third Quarter 2021 Financial Results November 10, 2021
November 7, 2021
BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial Ischemia
October 20, 2021
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Interventional Catheter Based Therapies
October 11, 2021
BioCardia Announces First Cross-Over Patient Treated in CardiAMP Cell Therapy Heart Failure Trial
October 6, 2021
BioCardia Announces Participation at the A.G.P. Biotech & Specialty Pharma Conference October 13, 2021 (Virtual Conference)
October 5, 2021
BioCardia Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021 (Virtual Conference)
September 8, 2021
BioCardia Reports Second Quarter 2021 Financial Results and Business Highlights
August 11, 2021
BioCardia Announces Japanese Patent on Imaging System for Targeting Cardiac Therapies
July 14, 2021
BioCardia Announces Fourth Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Study as Designed
June 22, 2021
BioCardia Announces European Patent Office Decision to Grant Patent on Autologous Cell Therapy Patient Selection Diagnostic Assay
June 20, 2021
BioCardia Reports First Quarter 2021 Financial Results and Business Highlights
May 12, 2021
BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates
April 25, 2021
BioCardia Reports 2020 Financial Results and Recent Business Highlights
March 29, 2021
BioCardia Signs Agreement With Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product Candidates
February 22, 2021
BioCardia Announces Clinical Leadership Changes
February 16, 2021
BioCardia Update on Cell Therapy Product Development and 2021 Milestones
February 1, 2021
Accomplished Biotech Executive Krisztina Zsebo, Ph.D. Joins BioCardia’s Board of Directors
January 10, 2021